CIK 0001468929 · <br>Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264042544
- Phone
- 215 702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- Open-market buys, last 90 days
- $757,691
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$757,691. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Kieser Brian Joseph Interim CEO | Purchase | +133,216 | $5.50 | $733K | 133,216 |
| 2026-11-10 | Kieser Brian Joseph Interim CEO | Purchase · Warrant to Purchase Common Stock (the "PIPE Warrant") | +133,216 | 133,216 | ||
| 2026-11-10 | Kieser Brian Joseph Interim CEO | Returned to the company · Convertible Promissory Note (before amendment) | +83,334 | 0 | ||
| 2026-11-10 | Kieser Brian Joseph Interim CEO | Grant or award · Convertible Promissory Note (as amended) | +181,819 | 181,819 | ||
| 2026-11-10 | Kieser Brian Joseph Interim CEO | Returned to the company · Warrant to Purchase Common Stock | +41,667 | 0 | ||
| 2026-11-10 | Kieser Brian Joseph Interim CEO | Grant or award · Existing Warrant (as amended) | +41,667 | 41,667 | ||
| 2026-11-10 | Kieser Brian Joseph Interim CEO | Returned to the company · Convertible Promissory Note (before amendment) | +458,334 | 0 | ||
| 2026-11-10 | Kieser Brian Joseph Interim CEO | Grant or award · Convertible Promissory Note (as amended) | +1,000,000 | 1,000,000 | ||
| 2026-11-10 | Kieser Brian Joseph Interim CEO | Returned to the company · Existing Warrant (before amendment) | +229,167 | 0 | ||
| 2026-11-10 | Kieser Brian Joseph Interim CEO | Grant or award · Existing Warrant (as amended) | +229,167 | 229,167 | ||
| 2026-11-10 | Ciardiello Steven Director | Returned to the company · Convertible Promissory Note (before amendment) | +2,084 | 0 | ||
| 2026-11-10 | Ciardiello Steven Director | Grant or award · Convertible Promissory Note (as amended) | +4,546 | 4,546 | ||
| 2026-11-10 | Ciardiello Steven Director | Returned to the company · Warrant to Purchase Common Stock | +1,042 | 0 | ||
| 2026-11-10 | Ciardiello Steven Director | Grant or award · Existing Warrant (as amended) | +1,042 | 1,042 | ||
| 2026-11-10 | Blackman Ian Howard Chief Financial Officer | Returned to the company · Convertible Promissory Note (before amendment) | +2,084 | |||
| 2026-11-10 | Blackman Ian Howard Chief Financial Officer | Grant or award · Convertible Promissory Note (as amended) | +4,546 | |||
| 2026-11-10 | Blackman Ian Howard Chief Financial Officer | Returned to the company · Warrant to Purchase Common Stock | +1,042 | |||
| 2026-11-10 | Blackman Ian Howard Chief Financial Officer | Grant or award · Existing Warrant (as amended) | +1,042 | |||
| 2026-11-10 | glassman steven mark Director | Purchase | +4,546 | $5.50 | $25K | 12,379 |
| 2026-11-10 | glassman steven mark Director | Purchase · Warrant to Purchase Common Stock (the "PIPE Warrant") | +4,546 | 4,546 |
Page 1 of 9 · 176 trades